Antioxidant power as a quality control marker for completeness of amotosalen and ultraviolet A photochemical treatments in platelet concentrates and plasma units

Transfusion

Volumn 56, Issue 7, 2016, Pages 1819-1827

  Abonnenc, Mélanie ^a   Crettaz, David ^a   Tacchini, Philippe ^b   Di Vincenzo, Luciana ^a   Sonego, Giona ^a   Prudent, Michel ^a   Tissot, Jean Daniel ^a   Lion, Niels ^a  

^a Transfusion Interrégionale CRS Laboratoire de Recherche sur les Produits Sanguins   (Switzerland)

^b EDEL for Life SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; ANTIOXIDANT; PHOTOSENSITIZING AGENT; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD DONOR; ELECTROCHEMICAL ANALYSIS; FEMALE; HUMAN; ILLUMINATION; MALE; PHOTOCHEMISTRY; PLASMA; QUALITY CONTROL; TECHNOLOGY; ULTRAVIOLET A RADIATION;

EID: 84977628936     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13638     Document Type: Article

References (27)

1. Alter HJ, Klein HG. The hazards of blood transfusion in historical perspective. Blood 2008;112:2617–26.
2. Vamvakas EC, Blajchman MA. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality. Transfus Med Rev 2010;24:77–124.
3. Irsch J, Lin L. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood system. Transfus Med Hemother 2011;38:19–31.
4. Kaiser-Guignard J, Canellini G, Lion N, et al. The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates. Blood Rev 2014;28:235–41.
5. Guide to the preparation, use and quality assurance of blood components. 18th ed (CD-P-TS). Strasbourg: EDQM Council of Europe; 2015. p. 102.
6. Bakkour S, Chafets DM, Wen L, et al. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light. Vox Sang 2014;107:351–9.
7. Isola H, Brandner D, Cazenave JP, et al. Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label. Vox Sang 2010;99:402.
8. Bruchmüller I, Losel R, Bugert P, et al. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets. Platelets 2005;16:441–5.
9. Wollowitz S. Targeting DNA and RNA in pathogens: mode of action of amotosalen HCl. Transfus Med Hemother 2004;31:11–6.
10. Bruchmüller I, Janetzko K, Bugert P, et al. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates. Transfusion 2005;45:1464–72.
11. Bakkour S, Chafets DM, Wen L, et al. Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA. Transfusion 2016;56:410–20.
12. Pietraforte D, Vona R, Marchesi A, et al. Redox control of platelet functions in physiology and pathophysiology. Antioxid Redox Signal 2014;21:177–93.
13. Krötz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004;24:1988–96.
14. Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008;28:s11–6.
15. Kitamura N, Kohtani S, Nakagaki R. Molecular aspects of furocoumarin reactions: photophysics, photochemistry, photobiology, and structural analysis. J Photochem Photobiol C Photochem Rev 2005;6:168–85.
16. Prudent M, Sonego G, Abonnenc M, et al. LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets. J Am Soc Mass Spectrom 2014;25:651–61.
17. Tacchini P, Lesch A, Neequaye A, et al. Electrochemical pseudo-titration of water-soluble antioxidants. Electroanalysis 2013;25:922–30.
18. Lesch A, Cortés-Salazar F, Prudent M, et al. Large scale inkjet-printing of carbon nanotubes electrodes for antioxidant assays in blood bags. J Electroanal Chem 2014;717-718:61–8.
19. Abonnenc M, Sonego G, Crettaz D, et al. In vitro study of platelet function confirms the contribution of the ultraviolet B (UVB) radiation in the lesions observed in riboflavin/UVB-treated platelet concentrates. Transfusion 2015;55:2219–30.
20. Abonnenc M, Sonego G, Kaiser-Guignard J, et al. In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step. Blood Transfus 2015;13:255–64.
21. Demirbag R, Yilmaz R, Erel O. The association of total antioxidant capacity with sex hormones. Scand Cardiovasc J 2005;39:172–6.
22. Caffieri S. Furocoumarin photolysis: chemical and biological aspects. Photochem Photobiol Sci 2002;1:149–57.
23. Chevion S, Chevion M. Antioxidant status and human health. Use of cyclic voltammetry for the evaluation of the antioxidant capacity of plasma and of edible plants. Ann N Y Acad Sci 2000;899:308–25.
24. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993;14:615–31.
25. Tzounakas V, Georgatzakou H, Kriebardis A, et al. Uric acid variation among regular blood donors is indicative of red blood cell susceptibility to storage lesion markers: a new hypothesis tested. Transfusion 2015;55:2659–71.
26. Lin L, Conlan MG, Tessman J, et al. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion 2005;45:1610–20.
27. Van der Meer PF, Bontekoe IJ, Daal BB, et al. Riboflavin and UV light treatment of platelets: a protective effect of platelet additive solution? Transfusion 2015;55:1900–8.